Get the Stockscreener App
432.80
0.63%
2.70
After Hours:
432.80
Medpace Holdings Inc stock is traded at $432.80, with a volume of 233.16K.
It is up +0.63% in the last 24 hours and down -14.88% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$430.10
Open:
$431.74
24h Volume:
233.16K
Relative Volume:
0.62
Market Cap:
$12.36B
Revenue:
$2.68B
Net Income/Loss:
$460.40M
P/E Ratio:
27.23
EPS:
15.8963
Net Cash Flow:
$711.00M
1W Performance:
+4.22%
1M Performance:
-14.88%
6M Performance:
-26.87%
1Y Performance:
+47.70%
1-Day Range:
$421.51
$434.86
1-Week Range:
$403.46
$434.86
52-Week Range:
$287.17
$628.92
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
432.80 | 12.28B | 2.68B | 460.40M | 711.00M | 15.90 |
TMO
Thermo Fisher Scientific Inc
|
448.28 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.00 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
559.37 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.37 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.96 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-18-26 | Upgrade | TD Cowen | Sell → Hold |
| Feb-13-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-10-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Medpace Holdings, Inc. to Contact the Firm Today! - ACCESS Newswire
$MEDP Shareholder Announcement: Medpace may have Misled - GlobeNewswire
Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth In The Healthcare Sector - DirectorsTalk Interviews
MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - TMX Newsfile
MEDP Stockholders Have Opportunity to Lead Medpace Holdings, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP AnnouncesMEDP - lincolnjournal.com
MEDP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - TMX Newsfile
Kohl’s, Medpace, General Motors, Lockheed Martin, Northrop Grumman: Stocks Making The Biggest Moves Today - MSN
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
MEDP Stock Price, Quote & Chart | MEDPACE HOLDINGS INC (NASDAQ:MEDP) - ChartMill
ROSEN, A LONGSTANDING LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMEDP - TMX Newsfile
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Laws - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMEDP - PR Newswire
INVESTOR ALERT: Medpace Holdings Inc. Investors with - GlobeNewswire
Turtle Creek Asset Management Inc.'s Medpace Holdings Inc(MEDP) Holding History - GuruFocus
Deadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders - GlobeNewswire
MEDP EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - PR Newswire
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Cancellation Rate Risks: SueWallSt - Morningstar
$MEDP Notification: Medpace Cancellation Rates Lead to Securities Fraud Class Action after 16% Stock Drop - ACCESS Newswire
$MEDP Stock Drop Notice: Medpace Stock Dropped 16% Leading to a Shareholder Securities Fraud Class ActionInvestors Notified of June 8 Deadline - ACCESS Newswire
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Medpace Holdings, Inc. – MEDP - ACCESS Newswire
Lead Plaintiff Deadline of June 8, 2026 in Shareholder - GlobeNewswire
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What Are the Core Allegations Against Medpace (MEDP) - Kavout
Medpace shareholders approve bylaw changes and board elections at annual meeting - Investing.com India
Medpace shareholders approve governance changes enhancing voting rights - TipRanks
Medpace (NASDAQ: MEDP) holders approve charter, bylaw changes and pay votes - Stock Titan
MEDP Deadline Alert: Medpace Investors with Losses are Notified - GuruFocus
Medpace Holdings stock (US5840631062): what the latest earnings mean for investors - AD HOC NEWS
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, - GlobeNewswire
MEDP Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Medpace Holdings, Inc. Securities LawsuitContact The Gross Law Firm - Morningstar
MEDP Deadline Alert: Medpace Investors with Losses are Notified of the Pending Securities Fraud Class Action Over Alleged Misrepresentations - TradingView
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
MEDP Stock Chart | MEDPACE HOLDINGS INC (NASDAQ:MEDP) - ChartMill
ROSEN, LEADING INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel ... - Caledonian Record
ROSEN, LEADING INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC - GlobeNewswire Inc.
Pomerantz LLP Issues Important Reminder to Medpace Holdings, Inc. Investors – MEDP - ACCESS Newswire
Medpace flags rising cancellations, near-term growth uncertain - MSN
Medpace (MEDP) director Dani S. Zander receives stock options grant - Stock Titan
Medpace (MEDP) director receives 1,110 stock options at $415.27 strike price - Stock Titan
Medpace (MEDP) director granted 1,110 options at $415.27 per share - Stock Titan
[Form 4] Medpace Holdings, Inc. Insider Trading Activity - Stock Titan
Medpace (MEDP) director Brian Carley receives 1,110-share stock option grant - Stock Titan
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud - GlobeNewswire
Northwestern Mutual Wealth Management Co. Purchases 100,968 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth And Potential Upside - DirectorsTalk Interviews
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):